An Analysis of Access to Finance for European Biotechnology Firms
The financial contest is probably the biggest barrier to European competitiveness in biotechnology. Very young start-up companies frequently struggle to raise cash to start the business. It is becoming more difficult than before. However, there are an increasing number of national and regional schemes that provide money to young companies.
Full 43 pages report is availabel for free at our Downloads section.
SURVELLIANCE OF ANTI-ALLERGIC DRUGS FROM INDORE LOCALITY OF MADHYA PRADESH
Allergy is a disorder of the immune system often also referred to as atopy. Allergic reactions occur to environmental substances known as allergens; these reactions are acquired, predictable and rapid.The present paper through the light on the marketing survey of Antiallergic drugs and a comparison of drugs, having less drug-drug interaction and adverse drug reaction which benefits the patient's compliance towards the use allergy. Market research of Antiallergic drugs was carried from Jan 2008 to May 2008; data's were collected from five doctor's cabin and ten chemist of Indore city.
Whole 8 pages article is availabel for download at Repository of Faramavita.Net
Following the success of our Total Market Forecasting conferences, VIBevents is now pleased to announce our 9th Annual Total Market Forecasting in Pharma Europe conference.
The scope of forecasting is changing rapidly and it is becoming even more challenging to present accurate forecasts in the fast-paced pharmaceutical environment.
Enhancing Observational Research to Demonstrate Drug Safety, Efficacy & Quality
Leveraging non-interventional studies to increase pharmacovigilance & post-marketing performance
23rd-24th October, 2008
RenaissanceHotel-ImperialRidingSchool, Vienna, Austria
This event will bring together a strong selection of speakers and discover their unique approaches and techniques in order to maximize observational research performance. Together, we will be examining the growing role of non-interventional research in achieving stronger safety results, better cost effectiveness outcomes and higher drug performance.
Communicating cost-effectiveness with key stakeholders in an exciting&complex market
18th-19th September, 2008
Hotel Crowne Plaza, Bratislava, Slovak Republic
This event will present a fresh and original perspective on communicating the cost-effectiveness of high-value drugs to key players and stakeholders in the former communistic countries of Central and Eastern Europe (CEE EU members, The Balkans and the former Soviet States).
eyeforpharma’s Sales Force Effectiveness
Russia-CIS Summit 2008 will show you how to boost the productivity of your
Sales Force by analyzing innovative CRM systems, incentive schemes and recruitment
techniques as well as exploring proven techniques to ensure your Reps deliver
the right message.
4th Annual Patient Recruitment and Retention in Clinical Trials
13th, 14th & 15th October, 2008, Amsterdam
Patient recruitment and retention in clinical trials is the leading
bottleneck in the new drug development pipeline. As the recruiting culture becomes more sophisticated and the forces affecting
patient enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical trials.
Top pharmaceutical marketing experts from around the globe will be gathering in Zurich October 21-22 for eyeforpharma’s Pharma Marketing Summit. The event will feature the most senior line-up eyeforpharma has ever assembled, with nine out of the top ten pharmas speaking, including four vice presidents responsible for some of the most cutting edge marketing programmes in the industry.
Accurate and complete expiry information now available with GenericsWeb Pipeline Scope
Finally, the generics industry has fast access to reliable key patent, SPC and data protection expiry information. Pipeline Scope, the latest release from industry experts GenericsWeb provides accurate and complete data for over 1400 INNs, across 37 countries, delivered through an interface that is easy to use and interpret.
Accurate and complete expiry information now available with GenericsWeb Pipeline Scope
Finally, the generics industry has fast access to reliable key patent, SPC and data protection expiry information. Pipeline Scope, the latest release from industry experts GenericsWeb provides accurate and complete data for over 1400 INNs, across 37 countries, delivered through an interface that is easy to use and interpret.
1st JULY 2008, Morristown, New Jersey.GenericsWeb, provider of premium Patent Intelligence Services to the Generic Pharmaceutical Industry, today opened the doors of its first US offices, strategically located in Morristown, New Jersey, the heart of the US pharmaceutical industry.
This is the best and largest gathering of pharma competitive intelligence executives!
Join us at this premier gathering and network with other key decision makers from companies such as Merck, Novartis, Wyeth, Amgen, BMS, Genzyme, Roche and more you as learn about the most pressing and relevant issues facing the competitive intelligence community today.
Is your company making the moves that are driving change?
It is essential that you are aware of the latest developments in biosimilars regulations, clinical assessment, manufacturing processes and pricing and reimbursement. Our 2nd Annual Biosimilars through a series of presentations and interactive discussions, you will gain new insight and share hands-on experiences in the latest trends and practices in the development of biosimilars both in Europe and the US.
Geneva, Switzerland; Westerbork, The Netherlands, April 21, 2008
RidePharm and 4Vision today announced their alliance for the further development of their customer and product portfolio
The companies will work together to increase their opportunities across Europe and beyond. In this alliance they will combine their capacities and present and future assignments.
Particular emphasis will be given to the all aspects in the field of business development and advisory functions for Biotech and Pharma companies.
Keep the competitive advantage in your market and develop a guideline to expanding your business in the CEE & CIS
There is a significant pressure on the industry to instant changes - like mitigating operational costs, lowering prices, meeting regulatory standards, sustaining global growth, just to name but a few. While pharma companies need to strive for commercializing drugs with maximized efficiency and minimized side effects, they also need to find out how they can overcome the challenges of successful cooperation with the local governments, parallel trade and EU regulations. Moreover, the CEE & CIS regions are constantly changing business environments.
'Conservative' pharmaceutical industry slow to take advantage of online marketing opportunities
While the internet has altered the landscape in the retail sector and revolutionized the airline industry, pharmaceutical companies have been slow to take advantage of the marketing opportunities offered by the medium. With existing sales and marketing strategies widely considered unsustainable, the industry needs to evolve and engage with its customers online, or it risks being left behind.
Under FP7, Joint Technology Initiatives (JTIs) have been
introduced to realise Public-Private Partnerships in research at
European level and IMI is one of the first JTIs. The EC and the
European Federation of Pharmaceutical Industries and Associations
(EFPIA) joined forces to set up IMI after the former has identified
biomedical research as a strategy priority to enhance the
competitiveness of the EU.
Nanotechnology is the emerging scientific field which includes the study of small, thin, carbon-based materials known as nanotubes (also called CNTs), which are becoming widely used in a plethora of products ranging from technologically advanced items utilized by NASA to everyday items used in the home. These nanotubes are increasingly popular due to their light weight and supreme strength, which is said to be stronger than steel.
Jobline - Job opportunities published at Farmavita.Net
At the JobLine you can post your job vacancies or search
for new job opportunities. We kindly invite all members to post their demand
for full-time/part-time jobs, temporary needs, consulting support, project
support, internship openings and other opportunities.
If you are recruiter or just looking for job ..... find below important presentation which will describe you why are social networks
are important to your career.
Farmavita.Net Journal 
Under FP7, Joint Technology Initiatives (JTIs) have been
introduced to realise Public-Private Partnerships in research at
European level and IMI is one of the first JTIs. The EC and the
European Federation of Pharmaceutical Industries and Associations
(EFPIA) joined forces to set up IMI after the former has identified
biomedical research as a strategy priority to enhance the
competitiveness of the EU.
